Zucara Therapeutics Funding: $50M Raised, Series B (2025)

Zucara Therapeutics is based in Toronto, ON, Canada. It has raised $50M in total funding. Latest round: Series B.

Zucara Therapeutics funding overview

Zucara Therapeutics is based in Toronto, ON, Canada. Zucara Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2025. The round record for Zucara Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Perceptive Xontogeny Venture Fund, Sanofi. 2 distinct backers are named across the disclosed rounds.

Zucara Therapeutics at a glance

Total raised
$50M
Latest round
Series B
Latest round date
May 2025
Headquarters
Toronto, ON, Canada
Notable investors
Perceptive Xontogeny Venture Fund, Sanofi

Frequently asked about Zucara Therapeutics funding

How much has Zucara Therapeutics raised?
Zucara Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Zucara Therapeutics?
Perceptive Xontogeny Venture Fund, Sanofi are named among the investors backing Zucara Therapeutics.
What was the latest Zucara Therapeutics funding round?
The most recent disclosed round is a Series B, announced in May 2025.
Where is Zucara Therapeutics based?
Zucara Therapeutics is based in Toronto, ON, Canada.
When did Zucara Therapeutics last raise?
The last disclosed Zucara Therapeutics round closed in May 2025 at Series B.

Round data for Zucara Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Toronto and backer lists below.

Companies related to Zucara Therapeutics (24)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026